American Diabetes Association. Standards of medical care in diabetes-2016. Diabetes Care. 2016;39(supp 1): S1-S112.
3.
American Geriatrics Society Expert Panel on Care of Older Adults with Diabetes Mellitus,
MorenoGMangioneCMKimbroLVaisbergE. Guidelines abstracted from the American Geriatrics Society guidelines for improving the care of older adults with diabetes mellitus: 2013 update. J Am Geri Soc. 2014;61:2020-2026.
4.
American Diabetes Association. Older adults-standards of medical care in diabetes, 2019. Diabetes Care. 2019;42 (suppl 1):S139-S147.
5.
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in individuals with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
6.
UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight individuals with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854-865.
7.
The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545-2559.
8.
The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in individuals with type 2 diabetes. N Engl J Med. 2008;358:2560-2572.
9.
DuckworthWAbrairaCMortizT, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129-139.
10.
LeRoithDBiesselsGJBraithwaiteSS, et al. Treatment of diabetes in older adults: an Endocrine Society clinical practice guideline. J Clin EndocrinolMetab. 2019;104:1-55.